Background illustration for clinical trials search

Paid Clinical Trials Washington State

Discover 1,593 paid clinical trials in Washington State. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

for
Chronic Lymphocytic Leukemia, Leukemia, Lymphocytic,
Location: Quebec, Bethesda MD, Richmond VA, West Palm Beach FL,
Sponsor: Loxo Oncology, Inc.

Sex: All

Age: 18+

Code: NCT05254743

Phase3, Recruiting

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors, Advanced Breast Cancer
Location: Boston MA, New Haven CT, Fairfax VA, Huntersville NC,
Sponsor: Ensem Therapeutics

Sex: All

Age: 18+

Code: NCT06993844

Phase1, Phase2, Recruiting

A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NCT05774756)

for
Hypothalamic Obesity,
Location: Boston MA, New York NY, Philadelphia PA, Birmingham AL,
Sponsor: Rhythm Pharmaceuticals, Inc.

Sex: All

Age: 4+

Code: NCT06760546

Phase3, Recruiting

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

for
Prostate Cancer (Adenocarcinoma)
Location: Saint John, Providence RI, Saint Johnsbury VT,
Sponsor: Canadian Cancer Trials Group

Sex: Male

Age: 18+

Code: NCT06592924

Phase3, Recruiting

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

for
Solid Tumor Cancer, Locally Advanced, Metastatic Solid Tumors,
Location: Washington D.C. DC, Sarasota FL, Atlanta GA, Houston TX,
Sponsor: Avenzo Therapeutics, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07038343

Phase1, Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma

for
Hepatocellular Carcinoma
Location: New Haven CT, Quebec, New York NY, New Brunswick NJ,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06921785

Phase3, Recruiting

Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)

for
Acute Decompensated Heart Failure
Location: Stony Brook NY, Philadelphia PA, Richmond VA,
Sponsor: Reprieve Cardiovascular, Inc

Sex: All

Age: 22+

Code: NCT06898515

Phase3, Recruiting

Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET

for
Somatostatin Receptor Positive (SSTR+),
Location: Hartford CT, New Haven CT, New York NY, Montreal,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 12 - 70+

Code: NCT06784752

Phase3, Recruiting

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

for
Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis,
Location: Boston MA, Providence RI, New York NY, Glen Burnie MD,
Sponsor: Spyre Therapeutics, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07012395

Phase2, Recruiting

XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)

for
Heart Transplant, Heart Failure, Transplant; Failure, Heart
Location: New York NY, Durham NC, Atlanta GA, Nashville TN,
Sponsor: XVIVO Perfusion

Sex: All

Age: 18+

Code: NCT06895070

Recruiting

Simethicone as Part of ERAS in Bariatric Surgery Patients

for
Simethicone, Bariatric Surgery, Post-operative Pain
Location: Tacoma WA
Sponsor: Madigan Army Medical Center

Sex: All

Age: 18 - 70+

Code: NCT06812832

Recruiting
Featured

Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: New York NY, New Brunswick NJ, Montreal,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06896916

Phase1, Recruiting

TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age

for
Cystic Fibrosis (CF)
Location: Boston MA, Richmond VA, Chapel Hill NC, Hollywood FL,
Sponsor: State University of New York at Buffalo

Sex: All

Age: 1 - 11

Code: NCT07048574

Recruiting

Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functional Outcomes in Patients With High-grade Myeloid Neoplasms, Acute Myeloid Leukemia, or B Acute Lymphoblastic Lymphoma/Leukemia

for
Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia,
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT06710418

Recruiting

A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

for
Metastatic Gastric Adenocarcinoma,
Location: Westbrook ME, Florham Park NJ, Flemington NJ,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT07043400

Phase3, Recruiting

A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

for
Type 1 Diabetes Mellitus
Location: Halifax, New Haven CT, New York NY, Philadelphia PA,
Sponsor: Sanofi

Sex: All

Age: 1 - 25

Code: NCT07088068

Phase3, Recruiting

"Sexual Health Assessment of TinidaZole Against M. Genitalium (SHAZAM)"

for
Mycoplasma Genitalium, Non-gonococcal Urethritis (NGU)
Location: Seattle WA
Sponsor: University of Washington

Sex: Male

Age: 18+

Code: NCT07088419

Phase2, Recruiting

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

for
Ulcerative Colitis, Obesity or Overweight
Location: London, New Bedford MA, Providence RI, Lebanon NH,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70

Code: NCT06937086

Phase3, Recruiting

Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)

for
Plaque Psoriasis
Location: St. John's, Portsmouth NH, Brighton MA, Milford MA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 40+

Code: NCT07116967

Phase3, Recruiting

School-based Paraeducator Education for Engagement at Recess

for
Autism Spectrum Disorder, Neurodevelopmental Disorders
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 5+

Code: NCT06559267

Recruiting

Popular cities in Washington State

SpokaneBellinghamSeattleKentEverettTacomaRenton